| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 30, 2003
Accepted on November 24, 2003
1 From The Division of Endocrinology, Metabolism, and Nutrition, Endocrine Research Unit, Mayo Clinic and Mayo Foundation, 200 First Street SW, 5-194 Joseph, Rochester, MN 55905 and Department of Molecular Biology, The University of Aarhus, Gustav Wieds Vej 10C, DK-8000, Aarhus C, Denmark.
* To whom correspondence should be addressed. E-mail: Conover.cheryl{at}mayo.edu.
Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein-4 (IGFBP-4), and appears to enhance local IGF bioavailability in response to injury. In this study, we determined the effect of growth factors and cytokines involved in the healing process on PAPP-A expression in human dermal fibroblasts. There was no effect of platelet-derived growth factor, epidermal growth factor, or basic fibroblast growth factor on PAPP-A mRNA expression in these cells. However, treatment with the proinflammatory cytokines, tumor necrosis factor-
(TNF-
) and interleukin-1
(IL-1
), resulted in time- and dose-dependent increases in PAPP-A mRNA and protein expression (3- to 4-fold maximal effects), which were prevented by actinomycin D. On the other hand, interferon-
(IFN-
) treatment markedly inhibited PAPP-A expression. IGFBP-4 proteolytic activity was increased 4-fold in media from TNF-
- and IL-1
- treated (1 nM) cells and decreased 40% in media from IFN-
-treated (1 nM) cells. IGF-I-stimulated [3H]thymidine incorporation was significantly enhanced by pretreatment with 1 nM TNF-
, and this enhancement was blocked in the presence of protease-resistant IGFBP-4. In conclusion, PAPP-A expression is regulated by inflammatory cytokines in adult human fibroblasts, with functional consequences on IGFBP-4 protease activity and IGF-I bioavailability. These data provide a mechanism for the regulation of PAPP-A in response to injury and further implicate PAPP-A in the wound healing processes.
Interleukin-1
Interferon-
Human fibroblasts
This article has been cited by other articles:
![]() |
S. Pellitero, J. L. Reverter, E. Pizarro, M. C. Pastor, M. L. Granada, D. Tassies, J.-C. Reverter, I. Salinas, and A. Sanmarti Pregnancy-Associated Plasma Protein-A Levels Are Related to Glycemic Control but Not to Lipid Profile or Hemostatic Parameters in Type 2 Diabetes Diabetes Care, December 1, 2007; 30(12): 3083 - 3085. [Full Text] [PDF] |
||||
![]() |
E. Capoluongo, F. Ameglio, P. Lulli, A. Minucci, C. Santonocito, P. Concolino, E. Di Stasio, S. Boccacci, V. Vendettuoli, G. Giuratrabocchetta, et al. Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E308 - E313. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Resch, R. D. Simari, and C. A. Conover Targeted Disruption of the Pregnancy-Associated Plasma Protein-A Gene Is Associated with Diminished Smooth Muscle Cell Response to Insulin-like Growth Factor-I and Resistance to Neointimal Hyperplasia after Vascular Injury Endocrinology, December 1, 2006; 147(12): 5634 - 5640. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Resch, C. Oxvig, L. K. Bale, and C. A. Conover Stress-Activated Signaling Pathways Mediate the Stimulation of Pregnancy-Associated Plasma Protein-A Expression in Cultured Human Fibroblasts Endocrinology, February 1, 2006; 147(2): 885 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Conover, L. K. Bale, S. C. Harrington, Z. T. Resch, M. T. Overgaard, and C. Oxvig Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol Am J Physiol Cell Physiol, January 1, 2006; 290(1): C183 - C188. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-P. Qin, S. Kokkala, J. Lund, N. Tamm, L.-M. Voipio-Pulkki, and K. Pettersson Molecular Distinction of Circulating Pregnancy-Associated Plasma Protein A in Myocardial Infarction and Pregnancy Clin. Chem., January 1, 2005; 51(1): 75 - 83. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |